169 related articles for article (PubMed ID: 17559064)
21. Effects of ligands or substrate of insulin-regulated aminopeptidase (IRAP) on trophoblast invasion.
Cohen M; Wuillemin C; Chai SY; Bischof P
J Pept Sci; 2008 Jul; 14(7):883-7. PubMed ID: 18275097
[TBL] [Abstract][Full Text] [Related]
22. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
[TBL] [Abstract][Full Text] [Related]
23. The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus--potential role in modulation of glucose uptake in neurones?
Fernando RN; Albiston AL; Chai SY
Eur J Neurosci; 2008 Aug; 28(3):588-98. PubMed ID: 18702730
[TBL] [Abstract][Full Text] [Related]
24. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
[TBL] [Abstract][Full Text] [Related]
26. Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain.
Ascher DB; Cromer BA; Morton CJ; Volitakis I; Cherny RA; Albiston AL; Chai SY; Parker MW
Biochemistry; 2011 Apr; 50(13):2611-22. PubMed ID: 21348480
[TBL] [Abstract][Full Text] [Related]
27. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
28. From angiotensin IV binding site to AT4 receptor.
Vanderheyden PM
Mol Cell Endocrinol; 2009 Apr; 302(2):159-66. PubMed ID: 19071192
[TBL] [Abstract][Full Text] [Related]
29. Sub-cellular localization of insulin-regulated membrane aminopeptidase, IRAP to vesicles in neurons.
Fernando RN; Luff SE; Albiston AL; Chai SY
J Neurochem; 2007 Aug; 102(3):967-76. PubMed ID: 17504262
[TBL] [Abstract][Full Text] [Related]
30. Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea.
Pilar Carrera M; Ramírez-Expósito MJ; Dueñas B; Dolores Mayas M; Jesús García M; De la Chica S; Cortés P; Ruíz-Sanjuan M; Martínez-Martos JM
Anticancer Res; 2006; 26(2A):1011-4. PubMed ID: 16619500
[TBL] [Abstract][Full Text] [Related]
31. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase.
Albiston AL; McDowall SG; Matsacos D; Sim P; Clune E; Mustafa T; Lee J; Mendelsohn FA; Simpson RJ; Connolly LM; Chai SY
J Biol Chem; 2001 Dec; 276(52):48623-6. PubMed ID: 11707427
[TBL] [Abstract][Full Text] [Related]
32. Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages.
Nikolaou A; Stijlemans B; Laoui D; Schouppe E; Tran HT; Tourwé D; Chai SY; Vanderheyden PM; Van Ginderachter JA
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):466-79. PubMed ID: 24532823
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Lew RA; Mustafa T; Ye S; McDowall SG; Chai SY; Albiston AL
J Neurochem; 2003 Jul; 86(2):344-50. PubMed ID: 12871575
[TBL] [Abstract][Full Text] [Related]
34. Identification of modulating residues defining the catalytic cleft of insulin-regulated aminopeptidase.
Ye S; Chai SY; Lew RA; Ascher DB; Morton CJ; Parker MW; Albiston AL
Biochem Cell Biol; 2008 Jun; 86(3):251-61. PubMed ID: 18523486
[TBL] [Abstract][Full Text] [Related]
35. Strain differences in the effects of angiotensin IV on mouse cognition.
Golding BJ; Overall AD; Brown G; Gard PR
Eur J Pharmacol; 2010 Sep; 641(2-3):154-9. PubMed ID: 20553916
[TBL] [Abstract][Full Text] [Related]
36. Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain.
Ye S; Chai SY; Lew RA; Albiston AL
Biol Chem; 2007 Apr; 388(4):399-403. PubMed ID: 17391061
[TBL] [Abstract][Full Text] [Related]
37. Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.
Lukaszuk A; Demaegdt H; Van den Eynde I; Vanderheyden P; Vauquelin G; Tourwé D
J Pept Sci; 2011 Aug; 17(8):545-53. PubMed ID: 21538707
[TBL] [Abstract][Full Text] [Related]
38. Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding.
Demaegdt H; Smitz L; De Backer JP; Le MT; Bauwens M; Szemenyei E; Tóth G; Michotte Y; Vanderheyden P; Vauquelin G
Br J Pharmacol; 2008 Jun; 154(4):872-81. PubMed ID: 18536739
[TBL] [Abstract][Full Text] [Related]
39. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
40. Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor.
Sköld C; Nikiforovich G; Karlén A
J Mol Graph Model; 2008 Feb; 26(6):991-1003. PubMed ID: 17936050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
